Bevacizumab: An Angiogenesis Inhibitor with Efficacy in Colorectal and Other Malignancies
The Annals of Pharmacotherapy
Vol. 38, No. 7, pp. 1258-1264
Stacey D Zondor, PharmD; Patrick J Medina, PharmD BCOP
DOI: 10.1345/aph.1D470
Go to journal article.

